Clinical characteristics of new psychoactive substances: A multicenter study.

[1]  K. Tusiewicz,et al.  Severe poisoning after smoking a mixture of 4-fluoroisobutyryl fentanyl (4-FiBF) and alpha-pyrolidinoisohexaphenone (α-PiHP). , 2021, Journal of forensic and legal medicine.

[2]  G. Martinotti,et al.  New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature , 2021, Medicina.

[3]  C. Chaou,et al.  Synthetic cathinone poisoning from ingestion of drug-laced “instant coffee packets” in Taiwan , 2021, Human & experimental toxicology.

[4]  H. Sumnall,et al.  New psychoactive substances: a review and updates , 2020, Therapeutic advances in psychopharmacology.

[5]  R. Jalali,et al.  Designers Drugs—A New Challenge to Emergency Departments—An Observational Study in Poland , 2020, Medicina.

[6]  F. Carvalho,et al.  Drinking to death: Hyponatraemia induced by synthetic phenethylamines. , 2020, Drug and alcohol dependence.

[7]  H. Peyrière,et al.  Use of new psychoactive substances to mimic prescription drugs: the trend in France. , 2020, Neurotoxicology.

[8]  Jih-Heng Li,et al.  New psychoactive substances in Taiwan: challenges and strategies. , 2020, Current opinion in psychiatry.

[9]  Lian-Yu Chen,et al.  Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department. , 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

[10]  R. Bruno,et al.  New psychoactive substances: challenges for drug surveillance, control, and public health responses , 2019, The Lancet.

[11]  J. Lappin,et al.  Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia. , 2019, Drug and alcohol dependence.

[12]  Y. Edel,et al.  Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs: A cross sectional study by hair testing (2012-2017). , 2019, Drug and alcohol dependence.

[13]  Lutea A A de Jong,et al.  The risk of emerging new psychoactive substances: The first fatal 3-MeO-PCP intoxication in The Netherlands. , 2019, Journal of forensic and legal medicine.

[14]  S. Ikeda,et al.  Changes of clinical symptoms in patients with new psychoactive substance (NPS)‐related disorders from fiscal year 2012 to 2014: A study in hospitals specializing in the treatment of addiction , 2019, Neuropsychopharmacology reports.

[15]  D. Walther,et al.  Analytical quantification, intoxication case series, and pharmacological mechanism of action for N-ethylnorpentylone (N-ethylpentylone or ephylone). , 2018, Drug testing and analysis.

[16]  M. Barratt,et al.  Typology of new psychoactive substance use among the general Australian population. , 2018, Drug and alcohol dependence.

[17]  M. Graw,et al.  MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations. , 2018, Forensic science international.

[18]  B. Venhuis,et al.  Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4‐Fluoroamphetamine: A Prospective Cohort Study , 2017, Annals of emergency medicine.

[19]  S. Lawrie,et al.  Characteristics of NPS use in patients admitted to acute psychiatric services in Southeast Scotland: a retrospective cross-sectional analysis following public health interventions , 2017, BMJ Open.

[20]  M. van Laar,et al.  Characterizing users of new psychoactive substances using psychometric scales for risk-related behavior. , 2017, Addictive behaviors.

[21]  U. Bonnet,et al.  New Psychoactive Substances (NPS) – a Challenge for the Addiction Treatment Services , 2017, Pharmacopsychiatry.

[22]  Laurent Karila,et al.  Synthetic Cathinones: A New Public Health Problem , 2015, Current neuropharmacology.

[23]  A. Abernethy,et al.  Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study , 2014, BMJ : British Medical Journal.

[24]  J. Sheridan,et al.  "They're legal so they're safe, right?" What did the legal status of BZP-party pills mean to young people in New Zealand? , 2010, The International journal on drug policy.

[25]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.